Comparing the Trend of Physical Activity and Caloric Intake between Lipid- Lowering Drug Users and Nonusers among Adults with Dyslipidemia: Korean National Health and Nutrition Examination Surveys (2010–2013)
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The purpose of this study was to compare the physical activity and caloric intake trends of lipid-loweringdrug users with those of non-users among Korean adults with dyslipidemia. Methods: This study was a repeated cross-sectional study with a nationally representative sample of 2,635 Koreanadults with dyslipidemia based on the 2010–2013 Korea National Health and Nutrition Examination Survey. Physicalactivity was assessed using the International Physical Activity Questionnaire, and caloric intake was estimatedthrough 24-hour dietary recall. All statistical analyses were conducted using IBM SPSS ver. 21.0 (IBM Co., Armonk,NY, USA). The changes in physical activity and caloric intake were investigated for lipid-lowering drug users andnon-users using generalized linear models. Results: The proportion of lipid-lowering drug users in the 2010–2013 survey population increased from 3.5% to5.0% (P<0.001). Among adults of dyslipidemia, total of 1,562 participants (56.6%) reported taking lipid-loweringdrugs, and 1,073 (43.4%) reported not taking lipid-lowering drugs. Drug users were more likely to be older and lesseducated and to have a diagnosis of diabetes, higher body mass index, and lower low density lipoprotein cholesterollevel. Physical activity trends were tested separately for the lipid-lowering drug users and non-users, and a significantdecrease was found among the drug users during the study period. Physical activity among the drug users in2013 was 38% lower (1,357.3±382.7 metabolic equivalent [MET]; P for trend=0.002) than in 2010 (2,201.4±442.6MET). In contrast, there was no statistically significant difference between drug users and non-users in the trend ofcaloric intake during the same period. Conclusion: Physical activity significantly decreased among lipid-lowering drug users between 2010 and 2013,which was not observed among non-users. The importance of physical activity may need to be re-emphasized forlipid-lowering drug users.
Abstract
Background: The purpose of this study was to compare the physical activity and caloric intake trends of lipid-loweringdrug users with those of non-users among Korean adults with dyslipidemia. Methods: This study was a repeated cross-sectional study with a nationally representative sample of 2,635 Koreanadults with dyslipidemia based on the 2010–2013 Korea National Health and Nutrition Examination Survey. Physicalactivity was assessed using the International Physical Activity Questionnaire, and caloric intake was estimatedthrough 24-hour dietary recall. All statistical analyses were conducted using IBM SPSS ver. 21.0 (IBM Co., Armonk,NY, USA). The changes in physical activity and caloric intake were investigated for lipid-lowering drug users andnon-users using generalized linear models. Results: The proportion of lipid-lowering drug users in the 2010–2013 survey population increased from 3.5% to5.0% (P<0.001). Among adults of dyslipidemia, total of 1,562 participants (56.6%) reported taking lipid-loweringdrugs, and 1,073 (43.4%) reported not taking lipid-lowering drugs. Drug users were more likely to be older and lesseducated and to have a diagnosis of diabetes, higher body mass index, and lower low density lipoprotein cholesterollevel. Physical activity trends were tested separately for the lipid-lowering drug users and non-users, and a significantdecrease was found among the drug users during the study period. Physical activity among the drug users in2013 was 38% lower (1,357.3±382.7 metabolic equivalent [MET]; P for trend=0.002) than in 2010 (2,201.4±442.6MET). In contrast, there was no statistically significant difference between drug users and non-users in the trend ofcaloric intake during the same period. Conclusion: Physical activity significantly decreased among lipid-lowering drug users between 2010 and 2013,which was not observed among non-users. The importance of physical activity may need to be re-emphasized forlipid-lowering drug users.
참고문헌 (17)
- Bezafibrate Infarction Prevention (BIP) study, "Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease", Circulation, 102, pp.21~27 (2000)
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), "Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report", Circulation, 106, pp.3143~3421 (2002)
- Stone NJ, "2013 ACC", AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology, Circulation, pp.2014, 129(25 Suppl 2)[DOI]
- Eckel RH, "2013 AHA", ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63(25 Pt B)[DOI]
- Lipid modification:cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease, "National Clinical Guideline Centre for Acute and Chronic Conditions", National Clinical Guideline Centre, ~ (2014)
- Lalonde L, "Comparing the benefits of diet and exercise in the treatment of dyslipidemia", Prev Med, 35, pp.16~24 (2002)
- The fifth and sixth Korea National Health and Nutrition Examination Survey guide book (KNHANES V-VI 2010-2013), "Ministry of Health and Welfare", Korea Centers for Disease Control and Prevention, ~ (2013)
- Kuklina EV, "Trends in high LDL cholesterol, cholesterol-lowering medication use, and dietary saturatedfat intake: United States, 1976-2010", NCHS Data Brief, 117, pp.1~8 (2013)
- Pencina MJ, "Application of new cholesterol guidelines to a population-based sample", N Engl J Med, 370, pp.1422~1431 (2014)
- Centers for Disease Control, "Trends in intake of energy and macronutrients--United States, 1971-2000", MMWR Morb Mortal Wkly Rep, 53, pp.80~82 (2004)
- Lofgren I, "Comparison of diet quality, physical activity and biochemical values of older adults either reporting or not reporting use of lipid-lowering medication", J Nutr Health Aging, 14, pp.168~172 (2010)
- Lytsy P, "Cardiovascular risk factor assessments and health behaviours in patients using statins compared to a nontreated population", Int J Behav Med, 19, pp.134~142 (2012)
- Sugiyama T, "Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins?", JAMA Intern Med, 174, pp.1038~1045 (2014)
- Hagstromer M, "The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity", Public Health Nutr, 9, pp.755~762 (2006)
- Craig CL, "International physical activity questionnaire: 12-country reliability and validity", Med Sci Sports Exerc, 35, pp.1381~1395 (2003)
- WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)
- Mann DM, "Dietary indiscretion and statin use", Mayo Clin Proc, 82, pp.951~957 (2007)